Last reviewed · How we verify
NCT05604339: ERUPTION-3
Study of Recovery and Blood Rheology Changes in Ultra-endurance Runners (ERUPTION-3)
trial in Physiology in 562 participants. Completed in 30 April 2023.
23 October 2022
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de la Réunion |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 562 |
| Start date | 20 September 2022 |
| Primary completion | 23 October 2022 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across Reunion |
Conditions studied
- Physiology — all drugs for Physiology →
Sponsor
Centre Hospitalier Universitaire de la Réunion
Who can join
18 and older, any sex, with Physiology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
While the acute consequences of an ultratrail are beginning to be well documented, data on the study of recovery in the aftermath of an event are much rarer. In order to overcome these various limitations, the main study of the ERUPTION-3 project is set up on the Grand Raid de La Réunion 2022 races. In the context of exercise responses, the rheological properties of blood can impact the endurance performance. In contrast to short-distance events, the study of blood rheology and red blood cells integrity in long-distance events such as ultra-endurance races is poorly documented in the literature. In the ancillary study, the work that is intended to be carried y out will complement the initial results found by a previous research on 23 runners during the Ultra Trail du Mont Blanc. This ancillary study will also be an opportunity to complete the data from the main study by studying the kinetics of biomarker recovery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05604339
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Physiology
Currently open trials in the same condition.
- NCT07163169 — Predicting Chemo Toxicity Using Geriatric Forms · active not recruiting
- NCT06864455 — Breastfeeding Relaxation Intervention Among Mothers of Preterm Infants in Hospital Sultan Abdul Aziz Shah (HSAAS) · NA · recruiting
Other Centre Hospitalier Universitaire de la Réunion trials
Trials by the same sponsor.
- NCT06697262 — Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia · NA · not yet recruiting
- NCT07444515 — Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients. · NA · not yet recruiting
- NCT07190560 — Against Chikungunya Virus and Neonatal Infection · NA · not yet recruiting
- NCT07365670 — Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Int · NA · not yet recruiting
- NCT06485310 — Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary M · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05604339 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Réunion
- Last refreshed: 14 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604339.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing